학술논문

Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions
Document Type
Review
Source
In: Critical Reviews in Oncology/Hematology. (Critical Reviews in Oncology/Hematology, April 2024, 196)
Subject
Language
English
ISSN
18790461
10408428